Advanced Immunization Management
引入新的或未充分利用的疫苗所需要考虑的事项
AIM主页 | 联系我们
English | Français | Bahasa Indonesia | Русский | 中文

内容

  • 欢迎
  • 流行性乙型脑炎
    • 疾病
    • 疾病负担
    • 控制策略
    • 疫苗相关事项
    • 免疫规划的实施
    • 评价和监测
    • 资源
    • 参考文献
参考文献
  1. Marquez L, Kean L. "Making Supervision Supportive and Sustainable: New Approaches to Old Problems," Maximizing Access and Quality Initiative, MAQ Paper No. 4, Washington DC: USAID; 2002. 可在以下网址获取: http://www.maqweb.org/maqdoc/MAQno4final.pdf.
  2. Tsai T. "New initiatives for the control of Japanese encephalitis by vaccination: Minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998," Vaccine, 2000;18(2):1-25.
  3. Halstead SB, Tsai TF. In: Plotkin S, Orenstein W, eds. Vaccines, Philadelphia: WB Saunders Press; 2004;919-958.
  4. World Health Organization (WHO). Weekly Epidemiological Record, No. 44, Geneva: WHO; 1998;73(44):337-344.
  5. Photo, Julie Jacobson.
  6. Halstead SB, Jacobson J. In: Chambers T, Monath T, eds. The Flaviviruses: Detection, Diagnosis and Vaccine Development, San Diego, USA: Elsevier Academic Press; 2003;103-138.
  7. Solomon T, Dung NM, Kneen R, Gainsborough M, Vaughn DW & Khanh VT. "Japanese encephalitis," J Neurol Neurosurg Psychiatry, 2000;68:405-15.
  8. Savage H, Miller B, House Mosquitoes of the U.S.A. "Culex pipiens complex," Wing Beats, 6(2):8-9; 1995.
  9. Yu YX. "Japanese encephalitis in China," Southeast Asian Journal of Tropical Medicine and Public Health, 1995;26(3):17-21.
  10. Xu Z. Five-Year Strategic Plan for the Control of Japanese Encephalitis in Bali, Indonesia (draft). Prepared by the International Vaccine Institute, Seoul, Korea, August 2002.
  11. Data provided by the Government of Andhra Pradesh, India. September 2001.
  12. World Health Organization (WHO). Assessing New Vaccines for National Immunization Programmes, ISBN 9290611545. Geneva: WHO; 2000. 可在以下网址获取: http://www.wpro.who.int/pdf/vaccines.pdf (275K, 39 pages).
  13. Surveillance of Japanese encephalitis, Meeting to discuss JE surveillance issues and make recommendations for surveillance guidelines and standards to be used for countries in the WPRO and SEARO WHO regions, Geneva: WHO, (July 5-6, 2004).
  14. Photo, S. del Sel.
  15. Jacobson J. Generic Intensified Hospital-Based Surveillance of Japanese Encephalitis, unpublished data, 2002.
  16. Supamit C, Presented at: Global Alliance for Vaccines and Immunization (GAVI). Setting the Global Agenda on Public Health Solutions and National Needs, June 18-19, 2002; Bangkok, Thailand. Minutes of The Joint Japanese Encephalitis Meeting of the Global Allince for Vaccines and Immunization (GAVI) South Asia & Asia Pacific Regional Working Groups.
  17. US Department of Defense Global Emerging Infections Surveillance and Response System (DoD-GEIS). ESSENCE: Electronic Surveillance System for the Early Notification of Community-based Epidemics, 2002. 可在以下网址获取: http://www.geis.ha.osd.mil/GEIS/SurveillanceActivities/ESSENCE/ESSENCE.asp.
  18. Verbal communication with Julie Jacobson, PATH (December 2003).
  19. International Vaccine Institute (IVI). Unpublished data. Policy Analysis of Japanese Encephalitis Immunization in China, 2002.
  20. Bista MB, Banerjee MK, Shin SH, et al. "Efficacy of single-dose SA14-14-2 vaccine against Japanese encephalitis: a case control study," Lancet, 2001;358:791-795.
  21. Halstead SB, Global Alliance for Vaccines and Immunization (GAVI). "Suppose there was no Japanese encephalitis vaccine," Setting the Global Agenda on Public Health Solutions and National Needs, Minutes from The Joint Japanese Encephalitis Meeting of the Global Alliance for Vaccines and Immunization (GAVI) South Asia & Asia Pacific Regional Working Groups. June 18-19, 2002; Bangkok, Thailand.
  22. Igarashi A. "Control of Japanese encephalitis in Japan: Immunization of humans and animals and vector control," Current Topics in Microbiology and Immunology, 2002;267:139-152.
  23. Endy TP, Nisalak A. "Japanese encephalitis virus: Ecology and epidemiology," Current Topics in Microbiology and Immunology, 2002;267:12-28.
  24. Mekong Basin Disease Surveillance Collaboration, Thailand Ministry of Public Health. Accessed November 5, 2004. 可在以下网址获取: http://epid.moph.go.th/mbds/disease_encephalitis.html.
  25. Hanna JN, Ritchie SA, Phillips DA, et al. "Japanese encephalitis in north Queensland, Australia, 1998," Medical Journal of Australia, 1999;170:533-536.
  26. Japanese Encephalitis Vaccine Details page. Children's Vaccine Program website, 2002. Accessed November 23, 2004. 可在以下网址获取: http://childrensvaccine.org/html/v_enceph_vac.htm.
  27. Benli Z, Min Z, Pinquan C, et al. "An 11 year follow-up of epidemiological effect Japanese encephalitis vaccine, live (SA14-14-2)," Chinese Journal of Biologicals, 2001;14(3).
  28. Monath, TP. "Japanese encephalitis vaccines: Current vaccines and future prospects," Current Topics in Microbiology and Immunology, 2002;267:106-138.
  29. China Ministry of Health (MOH). Guidelines for Japanese Encephalitis Control and Prevention, Beijing: MOH; 2004.
  30. PATH's Children's Vaccine Program (CVP). Guidelines for Implementing Supportive Supervision: A step-by-step guide with tools to support immunization, Seattle: PATH, 2003.
  31. In a conversation with James Cheyne (February 2004).
  32. Hennessy S, Zhengle L, Tsai TF, et al. "Effectiveness of live-attenuated Japanese encephalitis vaccine (SA 14-14-2): a case-control study," Lancet, 1996;347:1583-86.
  33. Plesner AM. "Allergic reactions to Japanese encephalitis vaccine," Immunology and Allergy Clinics of North America, 2003;23(4):665-697.
  34. Oya A. "Japanese encephalitis vaccine," Acta Paediatrica Japonica, 1988;30:175-184.
  35. Liu ZL, Hennessey S, Strom BL, et al. "Short-term safety of live attentuated Japanese encephalitis vaccine (SA14-14-2): Results of a randomised trial with 26,239 subjects," Journal of Infectious Disease, 1997;176:1366-1369.
  36. Ding D, Kilgore P, Clemens J, et al. Cost-effectiveness of routine immunization to control Japanese encephalitis in Shanghai, China, Bulletin of the WHO; 2003;81(5):334-342.
  37. World Health Organization (WHO). Introduction of new vaccines into national immunization programs - a documentation of Africa's experience, Geneva: WHO; 2001.
  38. Siraprapasiri T, Sawaddowudhipong W, Rojanasuphot S. "Cost benefit analysis of Japanese Encephalitis vaccination program in Thailand," Southeast Asian Journal of Tropical Medicine and Public Health, 1997;28(1):143-148.
  39. World Health Organization (WHO). Guidelines for estimating costs of introducing new vaccines into the national immunization system, Geneva: WHO; 2002. 可在以下网址获取: http://www.who.int/vaccines-documents/DocsPDF02/www665.pdf.
  40. World Health Organization (WHO). Introduction of hepatitis B vaccine into childhood immunization services: Management guidelines, including information for health workers and parents, WHO/V&B/01.31, Geneva: WHO; 2001. 可在以下网址获取: http://www.who.int/vaccines-documents/DocsPDF01/www613.pdf (232K, 55 pages).
  41. World Health Organization (WHO). Product Information Sheets, Geneva: WHO; 2000. 可在以下网址获取: http://www.who.int/vaccines-documents/DocsPDF00/www518.pdf.
  42. World Health Organization (WHO). Safety of mass immunization campaigns, Geneva: WHO; 2002. WHO/V&B/02.10. 可在以下网址获取: http://www.who.int/vaccines-documents/DocsPDF02/www669.pdf.
  43. World Health Organization (WHO). Procurement of vaccines for public-sector programmes: a reference manual, Geneva: WHO 1999. 可在以下网址获取: http://www.who.int/vaccines-access/procurement/PDF_Proc_Manual/.
  44. World Health Organization (WHO). WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions, WHO/V&B/00.09. Geneva: WHO; 2000. 可在以下网址获取: http://www.who.int/vaccines-access/vacman/mdvp/WHO00.09doc.pdf.
  45. Government of Andhra Pradesh, India. JE vaccine storage guidelines, unpublished data, 2004.
  46. World Health Organization (WHO). Immunization in Practice: A practical resource guide for health workers 2004 update, WHO/IVB/04.06. Geneva: WHO; 2004. 可在以下网址获取: http://www.who.int/vaccines-diseases/epitraining/SiteNew/iip/.
  47. PATH's Children's Vaccine Program (CVP). Immunizing Children Against Japanese Encephalitis, Seattle: PATH; 2003. Training Resource Series.
  48. World Health Organization (WHO). "Surveillance of adverse events following immunization: Field guide for managers of immunization programmes," WHO/EPI/TRAM/93.02REV.1, Geneva: WHO; 1993. 可在以下网址获取: http://www.who.int/vaccines-documents/DocsPDF/www9541.pdf.
  49. Catlin M. Mapping activities in capacity building relevant to immunization programs, unpublished data, 2001.
  50. World Health Organization (WHO). Increasing immunization coverage at the health facility level, WHO/V&B/02.20. Geneva: WHO; 2002. 可在以下网址获取: http://www.who.int/vaccines-documents/DocsPDF02/www721.pdf.
  51. Younger E, Wittet S, Hooks C, et al. Immunization and Child Health Materials Development Guide, Seattle: PATH; 2001. 可在以下网址获取: http://www.childrensvaccine.org/html/ip_clinical.htm.
  52. World Health Organization (WHO). WHO vaccine-preventable diseases: monitoring system 2003 global summary, WHO/V&B/03.20. Geneva: WHO; 2003. 可在以下网址获取: http://www.who.int/vaccines-documents/GlobalSummary/GlobalSummary.pdf.
请将所有的问题和意见反馈到 info@aim.path.org
八月 2005 v1.5
版权 © 2003-2005, Program for Appropriate Technology for Health (PATH). All rights reserved.